COMPANY PROFILE · UPDATED 18 NOV 2025

GentiBio

GentiBio is a biotherapeutics company developing engineered regulatory T cells (EngTregs) programmed to treat autoimmune allergic diseases. The early-stage biotherapeutics company co-founded by pioneers in Treg biology and synthetic…

gentibio.com ↗

This profile is unclaimed — do you work here? Claim it

Claim it →

Founded: 2020
Headcount: 94
Open roles: 0
Last raised: Series A · Sign in to view

LEADERSHIP

Founders & key people

Adel Nada

CEO at GentiBio

GentiBioVycellixCasebia TherapeuticsIntellia TherapeuticsCaladrius BiosciencesBaxter International Inc.Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians (UK)University of BaselAbbott Research & Development Leadership ProgramUniversity of California San Francisco

Andy Walker

CTO at GentiBio

AbCellera BiologicsGentiBioSelf EmployedJewel BiotherapeuticsJuno TherapeuticsAGC BiologicsUniversity of WashingtonUniversity of California BerkeleyUniversity of California SanThe George Washington University

Chandra Patel

David Rawlings

OPEN ROLES

Hiring at GentiBio

No open roles listed right now. Check back soon or search all jobs →

FUNDING

Capital raised

Total raised

$177,000,000

Investors

Avidity PartnersJDRF T1D FundMatrix Capital ManagementNovartis Venture FundOrbiMed AdvisorsRA Capital ManagementSeattle Children's Hospital

Funding rounds

Series A
Matrix Capital Management, OrbiMed Advisors, Seattle Children's Hospital, Avidity Partners, Novartis Venture Fund, JDRF T1D Fund, RA Capital Management
$157MAug 10, 2021
Seed
Novartis Venture Fund, OrbiMed Advisors, RA Capital Management
$20MAug 4, 2020

Funding data via Diffbot

Categorized in

Industry

Healthcare & Biotech Biotech & Drug Discovery

Industries

Software Companies Medical Organizations Biotechnology Companies

Tech Stack

Mysql Php Python Wordpress

LOCATIONS

Where they work

GentiBio Headquarters Location

Seattle, WA, 98103

Loading map…